Abbott Labs Strikes Again Over Depakote ER

Law360, New York (July 10, 2008, 12:00 AM EDT) -- Abbott Laboratories has filed a patent suit against Indian pharmaceutical company Dr. Reddy's Laboratories Ltd. to bar it from manufacturing a generic version of the anti-seizure drug Depakote ER that allegedly infringes four Abbott patents.

In a complaint filed Tuesday in the U.S. District Court for the District of New Jersey, Abbott alleges that Dr. Reddy's Laboratories Ltd. and co-defendant Dr. Reddy's Laboratories Inc., its wholly owned U.S.-based subsidiary, filed an abbreviated new drug application with the U.S. Food and Drug Administration to produce a generic...
To view the full article, register now.